Safety and Immunogenicity Study of Recombinant Human Rabies Immunoglobin (rhRIG) in Combination With Rabies Vaccine for Human Use With Human Rabies Immune Globulin (HRIG) in Combination With Rabies Vaccine for Human Use in Healthy Adult Subjects.
Clinical trial NCT02559921 · COMPLETED
Trial details
- NCT number
- NCT02559921
- Sponsor
- Beijing Chaoyang District Centre for Disease Control and Prevention
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2015-08-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.